Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms - News18
1 day ago•News18
Goldman Sachs Initiates Buy On Syngene, Neuland Labs & A Sell Rating On Laurus Labs | CNBC TV18
6 days ago•CNBC-TV18
Syngene To Neuland And Laurus: Goldman Sachs Initiates Coverage As India Expands Global Pharma Supply
6 days ago•Bloomberg Quint
Syngene Under Pressure As Mgmt Cuts FY24 Revenue Growth Guidance After Reporting Weak Q3 | CNBC TV18
2 months ago•CNBC-TV18
Syngene International Downgraded To ‘Sell’ By UBS On Revenue Growth Headwinds
3 months ago•Bloomberg Quint
Top Stock Picks By Gaurav Bissa Of Incred Equities; Syngene, HDFC Life | Stocks To Buy Today
4 months ago•ET NOW
Q2 Review: Strong Q2 For Syngene International
6 months ago•Bloomberg Quint
Syngene International Q2 net profit rises 14.22% to Rs 116.5 crore
6 months ago•Moneycontrol
Laurus Labs, Syngene, Ipca, Gland Pharma Report Export Growth In August | BQ Prime
7 months ago•BQ Prime
Biocon names Peter Bains as group CEO, will report to Kiran Mazumdar-Shaw
7 months ago•Business Today